Oral antidepressant formulation

申请公布号：

US7662805(B2)

申请号：

US20040003780

申请日期：

2004.12.06

申请公布日期：

2010.02.16

申请人：

MENDLEWICZ JULIEN;KRIWIN PHILIPPE;POWIS DE TENBOSSCHE ROLAND

发明人：

MENDLEWICZ JULIEN;KRIWIN PHILIPPE;POWIS DE TENBOSSCHE ROLAND

分类号：

A61K31/60;A01N33/02;A61K9/24;A61K31/135;A61K31/137;A61K31/5513;A61K31/675;A61K45/06;A61P25/24;C07C211/00;C07D307/87;C07D307/93

主分类号：

A61K31/60

摘要：

Oral antidepressant formulation comprising an effective antidepressant amount of at least one pharmaceutically acceptable antidepressant active agent and an effective amount lower than 50 mg of acetylsalicylic acid, derivatives of acetylsalicylic acid, or diaspirin, for reducing the onset of antidepressant action.